Market Overview:
The global testosterone cypionate market is expected to grow at a CAGR of 5.5% from 2018 to 2030. The growth in the market can be attributed to the increasing prevalence of testosterone deficiency and rising awareness about the benefits of testosterone replacement therapy (TRT). Additionally, growing geriatric population and increasing incidence of lifestyle-associated diseases are also contributing to the growth of the market. By type, 200 mg/mL segment is expected to account for a larger share in terms of revenue in 2018. This can be attributed to higher dosage requirement for TRT as compared with 100 mg/mL segment. By application, primary hypogonadism segment is estimated to account for a larger share in terms of revenue in 2018 owing high prevalence rateof primary hypogonadism across all regions.
Product Definition:
Testosterone Cypionate is a synthetic anabolic-androgenic steroid. It is derived from testosterone, which exhibits both androgenic and anabolic properties. Testosterone cypionate is most commonly used to treat low testosterone levels in men. It also has been used for treating chronic hepatitis C, burn victims, and AIDS patients. Testosterone cypionate injections are typically given every two to four weeks.
200 mg/mL:
200 mg/mL is the concentration of testosterone cypionate that has been used in medical and sports medicines for more than 40 years. It is a clear, sterile solution containing 200 mg of base per mL. Testosterone Cypionate 200mg/mL has been widely used by athletes as well as by people with no athletic training to increase muscle mass and improve performance levels.
100 mg/mL:
Testosterone Cypionate is a form of testosterone that is produced by the body, in response to signals from the brain. Testosterone Cypionate has been found to be effective in treating hypogonadism (Low T). It also helps with symptoms of Erectile Dysfunction (ED) and Libido.
Application Insights:
Primary hypogonadism held the largest share of around 60.0% in 2017 in terms of revenue as well as volume. The segment is further subdivided into two sub-segments, namely, low testosterone and hyperandrogenism. In men, primary hypogonadism is generally associated with aging and a low bio-available testosterone level due to a decrease in gonadal hormone production or an increase in gonadal resistance towards the action of hormones.
The late-onset hypogonadism segment is expected to witness the fastest growth rate over the forecast period owing to increasing awareness about Testosterone Cypionate treatment among doctors and patients alike.
Regional Analysis:
North America dominated the global market in 2017. The presence of key players, availability of efficient healthcare services and high awareness levels among patients are some factors responsible for its large share. In addition, increasing prevalence of chronic diseases such as diabetes is also expected to drive the demand for testosterone Cypionate in this region over the forecast period. According to a study conducted by CDC (Center for Disease Control & Prevention), from 2013 to 2016, around 30% population aged 6-19 years had been suffering from type 2 diabetes during their lifetime.
Asia Pacific is anticipated to be one of fastest growing regions due with rising disposable income and improving healthcare infrastructure especially in developing countries such as India.
Growth Factors:
- Increasing awareness about the benefits of testosterone cypionate therapy among aging men
- Growing demand for testosterone replacement therapy to treat various age-related disorders
- Rising prevalence of hypogonadism and other testosterone deficiency conditions in men
- Proliferation of online pharmacies and increasing availability of generic versions of the drug
- Growing focus on preventive health care and healthy aging
Scope Of The Report
Report Attributes
Report Details
Report Title
Testosterone Cypionate Market Research Report
By Type
200 mg/mL, 100 mg/mL
By Application
Primary Hypogonadism, Hypogonadotropic Hypogonadism, Late-Onset Hypogonadism
By Companies
Pfizer, Cipla, Sun Pharmaceutical, Teva, Perrigo, Hikma Pharmaceuticals
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
135
Number of Tables & Figures
95
Customization Available
Yes, the report can be customized as per your need.
Global Testosterone Cypionate Market Report Segments:
The global Testosterone Cypionate market is segmented on the basis of:
Types
200 mg/mL, 100 mg/mL
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Primary Hypogonadism, Hypogonadotropic Hypogonadism, Late-Onset Hypogonadism
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Pfizer
- Cipla
- Sun Pharmaceutical
- Teva
- Perrigo
- Hikma Pharmaceuticals
Highlights of The Testosterone Cypionate Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- 200 mg/mL
- 100 mg/mL
- By Application:
- Primary Hypogonadism
- Hypogonadotropic Hypogonadism
- Late-Onset Hypogonadism
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Testosterone Cypionate Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Testosterone Cypionate is a testosterone ester and an injectable form of testosterone. Testosterone Cypionate is available in aqueous suspension for intramuscular injection. Testosterone Cypionate was approved by the U.S. Food and Drug Administration (FDA) in 2002 for treatment of hypogonadism, or low levels of testosterone caused by various medical conditions.
Some of the major companies in the testosterone cypionate market are Pfizer, Cipla, Sun Pharmaceutical, Teva, Perrigo, Hikma Pharmaceuticals.
The testosterone cypionate market is expected to register a CAGR of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Testosterone Cypionate Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Testosterone Cypionate Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Testosterone Cypionate Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Testosterone Cypionate Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Testosterone Cypionate Market Size & Forecast, 2018-2028
4.5.1 Testosterone Cypionate Market Size and Y-o-Y Growth
4.5.2 Testosterone Cypionate Market Absolute $ Opportunity
Chapter 5 Global Testosterone Cypionate Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Testosterone Cypionate Market Size Forecast by Type
5.2.1 200 mg/mL
5.2.2 100 mg/mL
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Testosterone Cypionate Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Testosterone Cypionate Market Size Forecast by Applications
6.2.1 Primary Hypogonadism
6.2.2 Hypogonadotropic Hypogonadism
6.2.3 Late-Onset Hypogonadism
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Testosterone Cypionate Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Testosterone Cypionate Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Testosterone Cypionate Analysis and Forecast
9.1 Introduction
9.2 North America Testosterone Cypionate Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Testosterone Cypionate Market Size Forecast by Type
9.6.1 200 mg/mL
9.6.2 100 mg/mL
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Testosterone Cypionate Market Size Forecast by Applications
9.10.1 Primary Hypogonadism
9.10.2 Hypogonadotropic Hypogonadism
9.10.3 Late-Onset Hypogonadism
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Testosterone Cypionate Analysis and Forecast
10.1 Introduction
10.2 Europe Testosterone Cypionate Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Testosterone Cypionate Market Size Forecast by Type
10.6.1 200 mg/mL
10.6.2 100 mg/mL
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Testosterone Cypionate Market Size Forecast by Applications
10.10.1 Primary Hypogonadism
10.10.2 Hypogonadotropic Hypogonadism
10.10.3 Late-Onset Hypogonadism
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Testosterone Cypionate Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Testosterone Cypionate Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Testosterone Cypionate Market Size Forecast by Type
11.6.1 200 mg/mL
11.6.2 100 mg/mL
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Testosterone Cypionate Market Size Forecast by Applications
11.10.1 Primary Hypogonadism
11.10.2 Hypogonadotropic Hypogonadism
11.10.3 Late-Onset Hypogonadism
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Testosterone Cypionate Analysis and Forecast
12.1 Introduction
12.2 Latin America Testosterone Cypionate Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Testosterone Cypionate Market Size Forecast by Type
12.6.1 200 mg/mL
12.6.2 100 mg/mL
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Testosterone Cypionate Market Size Forecast by Applications
12.10.1 Primary Hypogonadism
12.10.2 Hypogonadotropic Hypogonadism
12.10.3 Late-Onset Hypogonadism
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Testosterone Cypionate Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Testosterone Cypionate Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Testosterone Cypionate Market Size Forecast by Type
13.6.1 200 mg/mL
13.6.2 100 mg/mL
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Testosterone Cypionate Market Size Forecast by Applications
13.10.1 Primary Hypogonadism
13.10.2 Hypogonadotropic Hypogonadism
13.10.3 Late-Onset Hypogonadism
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Testosterone Cypionate Market: Competitive Dashboard
14.2 Global Testosterone Cypionate Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Pfizer
14.3.2 Cipla
14.3.3 Sun Pharmaceutical
14.3.4 Teva
14.3.5 Perrigo
14.3.6 Hikma Pharmaceuticals
